Deborah Cohen

Author PubWeight™ 61.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Alcohol and environmental justice: the density of liquor stores and bars in urban neighborhoods in the United States. J Stud Alcohol Drugs 2007 2.66
2 Evaluation of the mental health benefits of yoga in a secondary school: a preliminary randomized controlled trial. J Behav Health Serv Res 2012 2.39
3 Rivaroxaban: can we trust the evidence? BMJ 2016 2.14
4 Understanding healing relationships in primary care. Ann Fam Med 2008 2.08
5 Why have UK doctors been deterred from prescribing Avastin? BMJ 2015 1.96
6 Economic analysis of physical activity interventions. Am J Prev Med 2011 1.66
7 Speaking of weight: how patients and primary care clinicians initiate weight loss counseling. Prev Med 2004 1.64
8 Medical device recalls and transparency in the UK. BMJ 2011 1.58
9 European drugs agency clashes with scientists over safety of GLP-1 drugs. BMJ 2013 1.50
10 Rejecting political correctness. BMJ 2005 1.47
11 Dabigatran: how the drug company withheld important analyses. BMJ 2014 1.42
12 The neighborhood alcohol environment and alcohol-related morbidity. Alcohol Alcohol 2009 1.41
13 How valid is the European Food Safety Authority's assessment of sports drinks? BMJ 2012 1.40
14 Out and about: association of the built environment with physical activity behaviors of adolescent females. Health Place 2011 1.37
15 Identifying walking trips from GPS and accelerometer data in adolescent females. J Phys Act Health 2011 1.18
16 Etiological correlates of vaginismus: sexual and physical abuse, sexual knowledge, sexual self-schema, and relationship adjustment. J Sex Marital Ther 2003 1.17
17 Quantifying the contribution of neighborhood parks to physical activity. Prev Med 2013 1.15
18 What makes an orphan drug? BMJ 2010 1.13
19 Multilevel spatio-temporal dual changepoint models for relating alcohol outlet destruction and changes in neighbourhood rates of assaultive violence. Geospat Health 2008 1.12
20 Vaginal spasm, pain, and behavior: an empirical investigation of the diagnosis of vaginismus. Arch Sex Behav 2004 1.12
21 The transcriptional repressor Mecp2 regulates terminal neuronal differentiation. Mol Cell Neurosci 2004 1.07
22 Social capital and the neighborhood alcohol environment. Health Place 2008 1.06
23 Determinants of social capital indicators at the neighborhood level: a longitudinal analysis of loss of off-sale alcohol outlets and voting. J Stud Alcohol Drugs 2007 1.03
24 The accuracy of endoscopic ultrasound for restaging esophageal carcinoma after chemoradiation therapy. Cancer 2004 1.03
25 Features of the Chronic Care Model (CCM) associated with behavioral counseling and diabetes care in community primary care. J Am Board Fam Med 2010 0.98
26 Use of qualitative methods and user-centered design to develop customized health information technology tools within federally qualified health centers to keep children insured. J Ambul Care Manage 2014 0.96
27 Revision rates for metal on metal hip joints are double that of other materials. BMJ 2011 0.95
28 Neighbourhood alcohol availability and gonorrhea rates: impact of social capital. Geospat Health 2009 0.92
29 Insiders criticise FDA's decision not to withdraw rosiglitazone. BMJ 2010 0.92
30 PSA testing: press coverage in UK and US is an ocean apart. BMJ 2009 0.91
31 HIV/AIDS is spreading fastest in eastern Europe and Asia. BMJ 2004 0.90
32 Impact of a new bicycle path on physical activity. Prev Med 2007 0.88
33 The evidence underpinning sports performance products: a systematic assessment. BMJ Open 2012 0.88
34 Will industry influence derail UN summit? BMJ 2011 0.88
35 Pressure mounts for companies to hand over data on antidiabetes drugs linked to pancreatic harm. BMJ 2013 0.87
36 Performance enhancement using a balanced scorecard in a Patient-centered Medical Home. Fam Med 2011 0.86
37 Concerns over data in key dabigatran trial. BMJ 2014 0.85
38 Examining role change in primary care practice. J Prim Care Community Health 2012 0.84
39 Proximity to urban parks and mental health. J Ment Health Policy Econ 2014 0.83
40 EMA consults public on plan to increase transparency of drug trial data. BMJ 2013 0.82
41 FDA is to assess data linking type 2 diabetes drugs with pancreatitis. BMJ 2013 0.81
42 Barrier in West Bank threatens residents' health care, says report. BMJ 2005 0.81
43 Reports of pancreatitis are 20-30 times more likely with GLP-1 drugs, analysis finds. BMJ 2013 0.80
44 Devices and desires: industry fights toughening of medical device regulation in Europe. BMJ 2013 0.80
45 Hispanic concentration and the conditional influence of collective efficacy on adolescent childbearing. Arch Pediatr Adolesc Med 2006 0.79
46 The Affordable Care Act's plan for consumer assistance with insurance moves states forward but remains a work in progress. Health Aff (Millwood) 2013 0.79
47 Hyperplasia from GLP-1 drugs is "not a surprise," say researchers. BMJ 2013 0.78
48 Investigations editor's reply to Holt and to Barnett and O'Hare. BMJ 2013 0.78
49 Two drugs for type 2 diabetes seem to raise risk of acute pancreatitis, study shows. BMJ 2013 0.77
50 Roche offers researchers access to all Tamiflu trials. BMJ 2013 0.77
51 Questions remain over safety and effectiveness of oseltamivir. BMJ 2012 0.77
52 Rebuilding from the rubble. BMJ 2006 0.77
53 Asylum seekers in detention centres receive poor medical care, MP says. BMJ 2008 0.77
54 NICE rules out NHS prescription of fingolimod for multiple sclerosis. BMJ 2011 0.76
55 Patients are let down by poor device regulation, warn surgeons. BMJ 2012 0.76
56 Questioning the timeline of H1N1 flu vaccination contracts. Nature 2010 0.75
57 My six day experience in the Middle East. BMJ 2005 0.75
58 Source of surgical instruments should be checked, BMA says. BMJ 2008 0.75
59 WINDOW: wideband demodulator for optical waveforms. Opt Express 2017 0.75
60 New obesity center at WVU offering comprehensive program.. W V Med J 2003 0.75
61 Manufacturer failed to disclose faulty device in rivaroxaban trial. BMJ 2016 0.75
62 Medtronic submits full data on spinal protein to independent scrutiny. BMJ 2011 0.75
63 European regulatory body recommends suspension of rosiglitazone. BMJ 2010 0.75
64 US regulator seeks advice on health risks of metal on metal hip implants. BMJ 2012 0.75
65 European Medicines Agency tightens rules on conflict of interest. BMJ 2010 0.75
66 Study on metal-on-metal hip implants was halted a year before UK regulator banned their use. BMJ 2012 0.75
67 Whistle while you work: an analysis of NHS foundation trust policies. BMJ 2010 0.75
68 DePuy knew about hip implant's high failure rate three years before it was recalled. BMJ 2013 0.75
69 Environmental groups criticise WHO plans to improve health. BMJ 2004 0.75
70 FDA puts rosiglitazone post-marketing trial on hold. BMJ 2010 0.75
71 Overhaul US licensing process for devices, urges Institute of Medicine. BMJ 2011 0.75
72 Agency tells surgeons not to use a type of hip implant cup liner because of high revision rates. BMJ 2012 0.75
73 Closing the vaccine gap among toddlers in N.J. family physicians' practices. J Okla State Med Assoc 2005 0.75
74 Donor countries should ensure donated funds reach health workers. BMJ 2007 0.75
75 Attacks on publicly funded trials: what happens when industry does not want to know the answer. BMJ 2015 0.75
76 Support for tomorrow's doctors: getting it right, meeting their needs. Occup Med (Lond) 2013 0.75
77 European Medicines Agency is to tighten up on advisers' conflicts of interest. BMJ 2012 0.75
78 Drugs agency grants its first licence to homoeopathic product. BMJ 2009 0.75
79 Blair pledges 150m pounds sterling to support and protect AIDS orphans. BMJ 2004 0.75
80 Who was who? Race and Jews in turn-of-the-century Britain. J Br Stud 2002 0.75
81 BMA meeting: Doctors urge government to lower age limit for cervical cancer screening. BMJ 2009 0.75
82 UK health secretary promises to tighten regulatory procedures for medical devices. BMJ 2012 0.75
83 Medical students should be added to GMC register, says judge. BMJ 2005 0.75
84 Device licensing bodies sometimes put business before safety, an investigation finds. BMJ 2012 0.75
85 MEP calls for tougher legislation to stop drug trials that could be considered as marketing. BMJ 2012 0.75
86 Are the odds shifting against pharma in the fight for cheaper treatment for macular degeneration? BMJ 2017 0.75
87 Providing nomadic people with health care. BMJ 2005 0.75
88 Commitment to tackling alcohol misuse is missing from UN summit declaration, experts say. BMJ 2011 0.75
89 Home care nurses: a study of the occurrence of culturally competent care. J Transcult Nurs 2003 0.75
90 Cancer drugs: high price, uncertain value. BMJ 2017 0.75